close

Enter

Log in using OpenID

Biomarker Research Services Market Adopt Next-Generation Tech 2018-2026

embed
Biomarkers are widely used in development of drugs. One of the primary processes through which biomarkers are accepted for use in drug development, is the drug approval process.
Biomarker Research Services Market Demands and
Growth Prediction 2018 to 2026
Biomarker Research Services Market by Service Type (Biomarker Research
Services, and CDx Research Services), By Disease Indication (Oncology,
Cardiovascular Disorder, Infectious Disease, Neurological Disorder,
Immunological Disorder, and Others), By End User (Hospitals, Specialty Clinics,
and Diagnostic Centers) and By Region (North America, Latin America, Europe,
Asia Pacific, the Middle East, and Africa) - Size, Share, Outlook, and Opportunity
Analysis, 2018-2026
The Global Biomarker Research Services Market size was valued at US$ 5,897.7 million in 2017,
and is expected to witness a robust CAGR of 13.5% over the forecast period (2018–2026).
Biomarkers are widely used in development of drugs. One of the primary processes through which
biomarkers are accepted for use in drug development, is the drug approval process. The biomarker is
included in the regulatory submission process for drug approval such as Investigational New Drug
(IND), Biologics License Disease Indications (BLA), or New Drug Disease Indication (NDA), and are
then accepted for use in that specific drug development program. Another process through which
biomarkers are accepted for use in drug development is the Biomarker Qualification Program (BQP),
which qualifies a biomarker for a particular context of use (COU), independent of a drug approval
submission. This pathway is intended for biomarkers that are used in multiple drug development
programs. Qualified biomarkers have the potential to offer valuable information that may help during
drug development.
Market Dynamics
Factors such as increasing initiatives for development of precision medicine, increasing prevalence of
chronic diseases, and increasing demand for development of companion diagnostics, is supporting the
growth of global biomarker research services market. For instance, in 2017, National Institutes of
Health launched Precision Medicine Initiative (PMI) with an investment of US$ 215 million to
accelerate biomedical research and offer clinicians new tools to select therapies that can be used in a
more individualized approach with patients. Moreover, potential of biomarkers in disease diagnosis,
and in companion diagnostics is expected to boost global biomarker research services market growth.
Organizations such as Covance, Inc., Charles River, and others are actively involved in providing
biomarker research services.
Ask For Sample Copy Of This Business Research Report :
https://www.coherentmarketinsights.com/insight/request-sample/2612
Biomarkers are increasingly being used in all areas of medicine to help predict and characterize
disease. The increasing focus on biomarkers is expected to significantly drive demand for biomarkers
research services in development and validation of new biomarkers. Biomarker research services are
provided by various contract research organizations for discovery, development, validation, and testing
of biomarkers. Different companies provide different types of research services to their clients,
however, most common types of services include discovery of a candidate biomarker, qualification,
verification, research assay optimization, biomarker validation, and commercialization.
Research institutes, pharmaceutical organizations, and biotechnology companies partner and
collaborate with biomarker research service providers for development, validation, and
commercialization of biomarkers, as well as companion diagnostics. Companion diagnostic is a
diagnostic test used with a therapeutic drug to determine the drug’s applicability in a specific person.
Companion diagnostics are developed based on companion biomarkers, biomarkers that prospectively
help predict response, or severe toxicity of a therapeutic drug.
Detailed Segmentation:
•Global Biomarker Research Services Market, By Service Type:
•Biomarker Research Services
•CDx Research Services
•Global Biomarker Research Services Market, By Disease Indication:
•Oncology
•Cardiovascular Disorder
•Infectious Disease
•Neurological Disorder
•Immunological Disorder
•Others
Some major players operating in the global biomarker research services market include Noble Life
Sciences, Inc., Reprocell Corporation, Coriell Institute, BioIVT, ICON Plc., SRI International, Inc.,
Charles River Laboratories, Inc., Nordic Bioscience A/S, Proteome Sciences Plc., and Covance Inc.
(Laboratory Corporation of America Holdings, Inc.)
Increasing diagnostic applications of biomarkers is expected to boost global biomarker research
services market growth over the forecast period
The use of biomarkers for diagnostics is increasing due to certain features of biomarkers, which include
rapid detection of specific diseases. Biomarkers are used in a wide variety of neurological diseases,
metabolic disorders, immune deregulation, and oncology. These help with detection of diseases such as,
cancer and Alzheimer’s. Biomarkers are further used to detect Hemolytic disease of the newborn,
Huntington disease, hereditary Hemochromatosis, and cystic fibrosis.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: [email protected]
Author
ravikiran
ravikiran221   document Email
Document
Category
Health and Medicine
Views
8
File Size
383 KB
Tags
research
1/--pages
Report inappropriate content